

浏览全部资源
扫码关注微信
1.复旦大学附属华山医院(上海 200040)
2.上海市嘉定区南翔医院(上海 201802)
Received:07 November 2025,
Published:10 March 2026
移动端阅览
王婷,吕玉宝,王轩,等.血府逐瘀汤治疗肺癌的研究进展:从临床应用到机制探索[J].上海中医药杂志,2026,60(3):19-27.
WANG Ting,LYU Yubao,WANG Xuan,et al.Research progress on Xuefu Zhuyu Decoction in treatment of lung cancer: from clinical application to mechanism exploration[J].Shanghai Journal of Traditional Chinese Medicine,2026,60(3):19-27.
王婷,吕玉宝,王轩,等.血府逐瘀汤治疗肺癌的研究进展:从临床应用到机制探索[J].上海中医药杂志,2026,60(3):19-27. DOI: 10.16305/j.1007-1334.2026.z20251107002.
WANG Ting,LYU Yubao,WANG Xuan,et al.Research progress on Xuefu Zhuyu Decoction in treatment of lung cancer: from clinical application to mechanism exploration[J].Shanghai Journal of Traditional Chinese Medicine,2026,60(3):19-27. DOI: 10.16305/j.1007-1334.2026.z20251107002.
血府逐瘀汤源于清代王清任所著《医林改错》,为中医活血化瘀经典名方。近年来,该方在肿瘤治疗领域展现出潜在价值,临床研究提示其联合化学疗法可增强抗肿瘤效果。通过系统综述血府逐瘀汤在肺癌治疗中的作用,重点探讨其有效成分在抑制肿瘤血管生成、阻断转移进程、调控细胞衰老及重塑肿瘤免疫微环境等方面的药理作用与分子机制,以阐释该方抗肺癌的现代科学内涵。
Xuefu Zhuyu Decoction, recorded in
Yilin Gaicuo
(
Corrections of Errors in Medical Classics
) written by Wang Qingren in the Qing Dynasty, is a classic famous formula for promoting blood circulation and resolving stasis in traditional Chinese medicine. In recent years, this prescription has shown poten
tial value for oncological treatment. Clinical studies have suggested that its combination with chemotherapy can enhance the anti-tumor effect. By systematically reviewing the role of Xuefu Zhuyu Decoction in the treatment of lung cancer, this paper focuses on exploring the pharmacological effects and molecular mechanisms of its active components in inhibiting tumor angiogenesis, blocking metastasis process, regulating cellular senescence, and remodeling the tumor immune microenvironment. The aim is to elaborate the modern scientific connotation of the anti-lung cancer effects of Xuefu Zhuyu Decoction.
BRAY F , LAVERSANNE M , SUNG H , et al . Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2024 , 74 ( 3 ): 229 - 263 .
王飞 , 郭赜铭 , 李纪宾 , 等 . 中国肺癌高发现场研究进展 [J]. 肿瘤综合治疗电子杂志 , 2024 , 10 ( 4 ): 14 - 19 .
NIU X , YOU Q , HOU K , et al . Autophagy in cancer development,immune evasion,and drug resistance [J]. Drug Resist Updat , 2025 , 78 : 101170 .
LI S , CHEN X , SHI H , et al . Tailoring traditional Chinese medicine in cancer therapy [J]. Mol Cancer , 2025 , 24 ( 1 ): 27 .
WANG X , LI J , CHEN R , et al . Active ingredients from Chinese medicine for combination cancer therapy [J]. Int J Biol Sci , 2023 , 19 ( 11 ): 3499 - 3525 .
王衍鸿 , 田建辉 , 罗斌 , 等 . 中医药调控自然杀伤细胞防治肺癌转移的研究进展 [J]. 上海中医药杂志 , 2024 , 58 ( 12 ): 170 - 178 .
ZHANG J , WU Y , TIAN Y , et al . Chinese herbal medicine for the treatment of intestinal cancer:preclinical studies and potential clinical applications [J]. Mol Cancer , 2024 , 23 ( 1 ): 217 .
孟田田 , 张桐桐 , 邓秋 , 等 . 血府逐瘀汤辅助XELOX化疗治疗对晚期肝癌患者血清HIF-1α及TSP-1表达的影响 [J]. 中西医结合肝病杂志 , 2022 , 32 ( 7 ): 606 - 609 .
吴莹 , 李媛 , 王晓燕 . 血府逐瘀汤联合西医化疗对气滞血瘀证晚期子宫颈癌患者近期疗效及生存期的影响 [J]. 中外医学研究 , 2024 , 22 ( 20 ): 139 - 142 .
舒敏 , 韩志红 , 韩妍 , 等 . 血府逐瘀汤对晚期宫颈癌化疗患者的疗效和安全性研究 [J]. 中国药师 , 2023 , 26 ( 12 ): 428 - 434 .
刘伟 , 张虹 , 郝正华 . 肺癌的中医药古代文献研究 [J]. 湖南中医杂志 , 2016 , 32 ( 12 ): 136 - 137 .
许玲 , 孙建立 . 中医肿瘤学概论 [M]. 上海 : 上海交通大学出版社 , 2017 .
刘殿龙 , 侯炜 . 从痰、瘀辨证论治肺癌机制探讨 [J]. 中华中医药杂志 , 2020 , 35 ( 2 ): 783 - 785 .
阮兴秋 . 周仲瑛教授从痰瘀辨治肺系难治病经验研究 [D]. 南京 : 南京中医药大学 , 2009 .
王祥麒 , 张克克 . 通调气血法在肺癌辨治中的应用体会 [J]. 中国中医基础医学杂志 , 2016 , 22 ( 2 ): 279 - 280 .
王佳 , 储真真 . 血瘀证与肺癌高凝状态关系的探讨 [C]//中华中医药学会. 中华中医药学会第二届岐黄论坛——血液病中医药防治分论坛论文集 . 北京 : 中华中医药学会 , 2014 : 888 - 891 .
付莫骄 , 曾永蕾 , 毛梦莹 , 等 . 血府逐瘀汤联合艾灸改善胃癌合并高凝状态临床疗效观察 [J]. 湖北中医杂志 , 2024 , 46 ( 4 ): 42 - 45 .
杨成林 , 冯伟峰 , 朱诗平 , 等 . 血府逐瘀汤加味联合依托泊苷和顺铂化疗方案治疗晚期肺癌的临床疗效及对血流指标的影响 [J]. 癌症进展 , 2020 , 18 ( 17 ): 1786 - 1789 .
乔新梅 , 赵金岭 . 血府逐瘀汤联合化疗治疗瘀阻肺络证小细胞肺癌40例疗效观察 [J]. 新中医 , 2013 , 45 ( 2 ): 55 - 56 .
张领兄 . 四君子汤合血府逐瘀汤联合安罗替尼治疗气虚血瘀型非小细胞肺癌的临床研究 [D]. 长沙 : 湖南中医药大学 , 2020 .
张喜峰 , 王新新 . 血府逐瘀汤联合EP化疗方案治疗小细胞肺癌瘀阻肺络证近期疗效观察 [J]. 亚太传统医药 , 2018 , 14 ( 1 ): 202 - 204 .
董强 , 刘桂芹 , 刘建新 , 等 . 血府逐瘀汤加味治疗中晚期小细胞肺癌临床研究 [J]. 河南中医 , 2014 , 34 ( 9 ): 1758 - 1760 .
吴琼 , 马海洋 , 王志武 , 等 . 活血化瘀法对肺癌放疗后肺纤维化的抑制作用 [J]. 中国临床研究 , 2017 , 30 ( 9 ): 1261 - 1263 .
姚舒婷 . 血府逐瘀汤改善晚期肺癌瘀血阻络证癌痛患者症状的价值探讨 [C]//重庆市健康促进与健康教育学会全科专委会. 2025精神医学与心理健康系列研讨会论文集 . 重庆 : 重庆市健康促进与健康教育学会全科专委会 , 2025 : 1643 - 1646 .
郑巧 , 周铁成 , 向生霞 . 血府逐瘀汤治疗晚期肺癌瘀血阻络证癌痛患者的临床研究 [J]. 中药药理与临床 , 2022 , 38 ( 2 ): 195 - 198 .
张帆 . 血府逐瘀汤加味改善中晚期非小细胞肺癌血瘀证患者高凝状态的临床研究 [D]. 成都 : 成都中医药大学 , 2022 .
李洁 . 血府逐瘀汤治疗瘀阻肺络型中晚期非小细胞肺癌患者血液高凝状态的临床研究 [D]. 济南 : 山东中医药大学 , 2020 .
晋逢晨 . 血府逐瘀汤治疗肺癌相关抑郁的临床研究 [D]. 成都 : 成都中医药大学 , 2023 .
陈昱极 . 血府逐瘀汤加减治疗非小细胞肺癌相关性失眠(气滞血瘀型)疗效的临床观察 [D]. 成都 : 成都中医药大学 , 2021 .
王理槐 , 张红 , 孙银辉 , 等 . 血府逐瘀汤基于Wnt信号通路对非小细胞肺癌细胞生长的抑制作用 [J]. 中医临床研究 , 2022 , 14 ( 1 ): 58 - 60 .
王理槐 , 孙银辉 , 张领兄 , 等 . 血府逐瘀汤对非小细胞肺癌荷瘤小鼠GSK-3β与β-catenin表达的影响 [J]. 现代中西医结合杂志 , 2022 , 31 ( 5 ): 603 - 607 .
王理槐 , 孙银辉 , 张领兄 , 等 . 基于Wnt/β-catenin信号通路探讨血府逐瘀汤在非小细胞肺癌EGFR-TKI获得性耐药中的作用 [J]. 陕西中医 , 2022 , 43 ( 4 ): 427 - 431 .
李燕 , 朱亚楠 , 张丽菡 , 等 . 血府逐瘀汤联合顺铂促进MHC-Ⅰ表达抑制肺癌EMT的机制研究 [J/OL]. 中药材 , 2025 [ 2025-12-03 ]. https://doi.org/10.13863/j.issn1001-4454.2025.11.032 https://doi.org/10.13863/j.issn1001-4454.2025.11.032 .
傅春燕 , 刘永辉 , 曾立 , 等 . 血府逐瘀汤化学成分、药理作用及临床应用研究进展 [J]. 亚太传统医药 , 2024 , 20 ( 5 ): 232 - 237 .
ZHANG X , JIANG Z , ZHANG L , et al . Identification of prototype compounds and their metabolites in rats' serum from Xuefu Zhuyu Decoction by UPLC-Q-TOF/MS [J]. Chin Herb Med , 2022 , 15 ( 1 ): 139 - 150 .
FU C , XIA Z , LIU Y , et al . Qualitative analysis of major constituents from Xue Fu Zhu Yu Decoction using ultra high-performance liquid chromatography with hybrid ion trap time-of-flight mass spectrometry [J]. J Sep Sci , 2016 , 39 ( 17 ): 3457 - 3468 .
MAHAKI H , NOBARI S , TANZADEHPANAH H , et al . Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition:Therapeutic strategies and insights [J]. Biomed Pharmacother , 2025 , 186 : 118023 .
FUKUMURA D , KLOEPPER J , AMOOZGAR Z , et al . Enhancing cancer immunotherapy using antiangiogenics:opportunities and challenges [J]. Nat Rev Clin Oncol , 2018 , 15 ( 5 ): 325 - 340 .
LAWLER J . Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1 [J]. Semin Cancer Biol , 2022 , 86 ( Pt 2 ): 126 - 135 .
CAI X , CHEN Z , PAN X , et al . Inhibition of angiogenesis,fibrosis and thrombosis by tetramethylpyrazine:mechanisms contributing to the SDF-1/CXCR4 axis [J]. PLoS One , 2014 , 9 ( 2 ): e88176 .
JIA Y , WANG Z , ZANG A , et al . Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling [J]. Int J Oncol , 2016 , 48 ( 5 ): 2079 - 2086 .
林卫佳 , 刘志 , 张秀珑 , 等 . 川芎嗪联合顺铂对小鼠肿瘤血管生成的研究 [J]. 中国临床药理学杂志 , 2018 , 34 ( 3 ): 285 - 287 .
ZHANG P , LAI X , ZHU M H , et al . Saikosaponin A,a triterpene saponin,suppresses angiogenesis and tumor growth by blocking VEGFR2-mediated signaling pathway [J]. Front Pharmacol , 2021 , 12 : 713200 .
ZHANG J , LI J , SONG H , et al . Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation [J]. Biomed Pharmacother , 2019 , 109 : 806 - 814 .
FARES J , FARES M Y , KHACHFE H H , et al . Molecular principles of metastasis:a hallmark of cancer revisited [J]. Signal Transduct Target Ther , 2020 , 5 ( 1 ): 28 .
GUO S , HUANG J , LI G , et al . The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis [J]. Mol Cancer , 2023 , 22 ( 1 ): 193 .
LIU Z , CHEN J , REN Y , et al . Multi-stage mechanisms of tumor metastasis and therapeutic strategies [J]. Signal Transduct Target Ther , 2024 , 9 ( 1 ): 270 .
SHI X , WANG X , YAO W , et al . Mechanism insights and therapeutic intervention of tumor metastasis:latest developments and perspectives [J]. Signal Transduct Target Ther , 2024 , 9 ( 1 ): 192 .
WU Q , CHEN G L , LI Y J , et al . Paeoniflorin inhibits macrophage-mediated lung cancer metastasis [J]. Chin J Nat Med , 2015 , 13 ( 12 ): 925 - 932 .
LEE Y S , MUN J G , PARK S Y , et al . Saikosaponin D inhibits lung metastasis of colorectal cancer cells by inducing autophagy and apoptosis [J]. Nutrients , 2024 , 16 ( 12 ): 1844 .
ZHENG S , XIE Z , ZHOU Z , et al . Intervening non-small-cell lung cancer progression by cell membrane coated platycodin D via regulating hsa-miR-1246/FUT9/GSK3β pathway [J]. Int J Nanomedicine , 2025 , 20 : 1661 - 1678 .
SCHMITT C A , WANG B , DEMARIA M . Senescence and cancer-role and therapeutic opportunities [J]. Nat Rev Clin Oncol , 2022 , 19 ( 10 ): 619 - 636 .
DONG Z , LUO Y , YUAN Z , et al . Cellular senescence and SASP in tumor progression and therapeutic opportunities [J]. Mol Cancer , 2024 , 23 ( 1 ): 181 .
WANG L , LANKHORST L , BERNARDS R . Exploiting senescence for the treatment of cancer [J]. Nat Rev Cancer , 2022 , 22 ( 6 ): 340 - 355 .
SALEH T , CARPENTER V J , BLOUKH S , et al . Targeting tumor cell senescence and polyploidy as potential therapeutic strategies [J]. Semin Cancer Biol , 2022 , 81 : 37 - 47 .
COLUCCI M , SARILL M , MADDALENA M , et al . Senescence in cancer [J]. Cancer Cell , 2025 , 43 ( 7 ): 1204 - 1226 .
DENG Y , CHEN Q , YANG X , et al . Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment [J]. Theranostics , 2024 , 14 ( 3 ): 1224 - 1240 .
ORTIZ-MONTERO P , LONDOÑO-VALLEJO A , VERNOT J P . Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line [J]. Cell Commun Signal , 2017 , 15 ( 1 ): 17 .
CHEN X , YUAN M , ZHONG T , et al . LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence [J]. Cancer Lett , 2024 , 593 : 216930 .
LIU H , ZHAO D , LI H , et al . Blocking iASPP/Nrf2/M-CSF axis improves anti-cancer effect of chemotherapy-induced senescence by attenuating M2 polarization [J]. Cell Death Dis , 2022 , 13 ( 2 ): 166 .
SUN L , LI Y , ZHAO R , et al . Platycodin D2 enhances P21/CyclinA2-mediated senescence of HCC cells by regulating NIX-induced mitophagy [J]. Cancer Cell Int , 2024 , 24 ( 1 ): 79 .
WU Y , CHEN L , PI D , et al . Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway [J]. Front Pharmacol , 2025 , 16 : 1532579 .
WANG Z , MA L , SU M , et al . Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling [J]. Cell Death Dis , 2018 , 9 ( 2 ): 217 .
ISWARYA B R , JOHN C M . Modulating senescence-associated secretory phenotype-driven paracrine effects to overcome therapy -induced senescence: senolytic effects of hesperidin and quercetin in A549 lung adenocarcinoma cells [J]. Mol Biol Rep , 2025 , 52 ( 1 ): 795 .
TAKAYA K , KISHI K . Ligustilide,a novel senolytic compound isolated from the roots of angelica acutiloba [J]. Adv Biol (Weinh) , 2024 , 8 ( 10 ): e2300434 .
ZHU R Z , LI B S , GAO S S , et al . Luteolin inhibits H2O2-induced cellular senescence via modulation of SIRT1 and p53 [J]. Korean J Physiol Pharmacol , 2021 , 25 ( 4 ): 297 - 305 .
YAN Y , HUANG H , SU T , et al . Luteolin mitigates photoaging caused by uva-induced fibroblast senescence by modulating oxidative stress pathways [J]. Int J Mol Sci , 2025 , 26 ( 5 ): 1809 .
PERROTT K M , WILEY C D , DESPREZ P Y , et al . Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells [J]. Geroscience , 2017 , 39 ( 2 ): 161 - 173 .
WANG Z , GUO H , SONG Y , et al . Lung cancer tumor immune microenvironment:analyzing immune escape mechanisms and exploring emerging therapeutic targets [J]. Front Immunol , 2025 , 16 : 1597686 .
CHEN K , LUO L , LI Y , et al . Reprogramming the immune microenvironment in lung cancer [J]. Front Immunol , 2025 , 16 : 1684889 .
XU L , ZOU C , ZHANG S , et al . Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors [J]. J Hematol Oncol , 2022 , 15 ( 1 ): 87 .
LV B , WANG Y , MA D , et al . Immunotherapy:Reshape the tumor immune microenvironment [J]. Front Immunol , 2022 , 13 : 844142 .
YANG R , PEI T , HUANG R , et al . Platycodon grandiflorum triggers antitumor immunity by restricting PD-1 expression of CD8 + T cells in local tumor microenvironment [J]. Front Pharmacol , 2022 , 13 : 774440 .
GAO M , ZHANG D , JIANG C , et al . Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression [J]. Biomed Pharmacother , 2023 , 166 : 115317 .
ZHU J , HUANG R , YANG R , et al . Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8 + T cell infiltration [J]. Cancer Cell Int , 2021 , 21 ( 1 ): 529 .
WANG X J , REN J L , ZHANG A H , et al . Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients:Current evidence [J]. Mass Spectrom Rev , 2019 , 38 ( 4-5 ): 380 - 402 .
ALWAN A M , ROKAYA D , KATHAYAT G , et al . Onco-immunity and therapeutic application of amygdalin:A review [J]. J Oral Biol Craniofac Res , 2023 , 13 ( 2 ), 155 - 163 .
SPANOUDAKI M , STOUMPOU S , PAPADOPOULOU S K , et al . Amygdalin as a promising anticancer agent:Molecular mechanisms and future perspectives for the development of new nanoformulations for its delivery [J]. Int J Mol Sci , 2023 , 24 ( 18 ): 14270 .
SAITO J , ONISHI N , YAMASAKI J , et al . Benzaldehyde suppresses epithelial-mesenchymal plasticity and overcomes treatment resistance in cancer by targeting the interaction of 14-3-3ζ with H3S28ph [J]. Br J Cancer , 2025 , 133 ( 1 ): 27 - 39 .
SHI J , CHEN Q , XU M , et al . Recent updates and future perspectives about amygdalin as a potential anticancer agent:A review [J]. Cancer Med , 2019 , 8 ( 6 ): 3004 - 3011 .
SUN Y , ZHU G , ZHAO R , et al . Deapioplatycodin D inhibits glioblastoma cell proliferation by inducing BNIP3L-mediated incomplete mitophagy [J]. Cancer Cell Int , 2025 , 25 ( 1 ): 11 .
TEMIS-CORTINA J A , PRADA-RAMÍREZ H A , RÍOS-GUERRA H , et al . Response of akkermansia muciniphila to bioactive compounds: Effects on its abundance and activity [J]. Fermentation , 2025 , 11 ( 8 ): 427 .
SONNEMANN J , HARTWIG M , PLATH A , et al . Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells [J]. Cancer Lett , 2006 , 232 ( 2 ): 148 - 160 .
0
Views
0
下载量
0
CSCD
0
CNKI被引量
Publicity Resources
Related Articles
Related Author
Related Institution
沪公网安备 31011502015228号